What is Computational Medicine and Drug Discovery?
Computational Medicine involves a combination of mathematics, engineering and computer science. It is an emerging field which is devoted to develop for understanding the mechanisms, diagnosis and treatment of human disease. The main aim of this field is to develop computational models for molecular biology, physiology, and anatomy of disease, and apply these models to improve patient care.
Drug discovery is process through which new medicines have been discovered. It includes various disciples such as biology, chemistry and pharmacology. Drug discovery is a process which involves the identification of drug target, synthesis, characterization, screening, and assays for therapeutic efficacy.
What are the applications of Computational Medicine and Drug Discovery Software?
Computational medicine and drug discovery software play an important role in the development drugs for various diseases such as cancer and other genetic disorders. Computational medicine also helps to detect the fault in the genes and thus helps to predict the cause of the disease. It is widely used disease monitoring and medical imaging and personalized medicine. Computational medicine and drug discovery software are used to understand the protein – protein interactions as well as protein – ligand interactions which makes it easier to find the drug target.
Computational Medicine and Drug Discovery Software Market
Market Research and Market Trends of Computational Medicine and Drug Discovery Software:
Nvidia is strategically shifting its focus from computer hardware industry to healthcare industry. It has partnered with companies like GE, Mayo Clinic and Nuance healthcare to define the workflow. They have been developing a computational software which would aid to virtualize all the hospital work and all the different instruments. These computational approaches hold a promise to improve the image quality and help the doctor to predict the diseases which would otherwise take time. They are also focused on developing deep learning in genomics and drug discovery and make way towards personalized medicine.
Fujitsu Laboratories Ltd. and Fujitsu Limited announced the development of molecular simulation technology for drug discovery. This development can accurately estimate binding affinity between the target protein and the chemical substance which helps to predict the drug’s efficiency. This technique also estimates the degree of torsion in a chemical substance as well as the impact of neighboring atoms and thus will help in the development of new targeted therapies.
Researchers from KAIST, Korea developed DeepDDI, a computational framework that accurately predicts and generates 86 types of drug-drug and drug-food interactions. These interactions can help us to predict unexpected pharmacological effects such as adverse drug events (ADEs) and other unknown mechanisms. However, the current prediction methods do not provide detailed drug interactions.
In February 2018, Roche acquired oncology tech company Flatiron Health in order to implement the use of artificial intelligence as another tool to facilitate drug discovery and help the company progress. This acquisition with Flatrion Health provided the required technology and data analytics needed for Roche as well as oncology research and development across the industry.
Who are the Major Players in Computational Medicine and Drug Discovery Software market?
The companies referred in the market research report are Compugen Ltd., Certara, L.P., Dassault Systemes, Schrödinger LLC, Genedata AG and several others.
What is our report scope?
The report incorporates in-depth assessment of the competitive landscape, product market sizing, product benchmarking, market trends, product developments, financial analysis, strategic analysis and so on to gauge the impact forces and potential opportunities of the market. Apart from this the report also includes a study of major developments in the market such as product launches, agreements, acquisitions, collaborations, mergers and so on to comprehend the prevailing market dynamics at present and its impact during the forecast period 2018-2023.
Key Takeaways from this Report
Evaluate market potential through analyzing growth rates (CAGR %), Volume (Units) and Value ($M) data given at country level – for product types, end use applications and by different industry verticals.
Understand the different dynamics influencing the market – key driving factors, challenges and hidden opportunities.
Get in-depth insights on your competitor performance – market shares, strategies, financial benchmarking, product benchmarking, SWOT and more.
Analyze the sales and distribution channels across key geographies to improve top-line revenues.
Understand the industry supply chain with a deep-dive on the value augmentation at each step, in order to optimize value and bring efficiencies in your processes.
Get a quick outlook on the market entropy – M&A’s, deals, partnerships, product launches of all key players for the past 4 years.
Evaluate the supply-demand gaps, import-export statistics and regulatory landscape for more than top 20 countries globally for the market.
This report will be delivered within 2 business days.
1.1. Definitions and Scope
2. Computational Medicine And Drug Discovery Software Market - Executive summary
2.1. Market Revenue, Market Size and Key Trends by Company
2.2. Key Trends by type of Application
2.3. Key Trends segmented by Geography
3. Computational Medicine And Drug Discovery Software Market
3.1. Comparative analysis
3.1.1. Product Benchmarking - Top 10 companies
3.1.2. Top 5 Financials Analysis
3.1.3. Market Value split by Top 10 companies
3.1.4. Patent Analysis - Top 10 companies
3.1.5. Pricing Analysis
4. Computational Medicine And Drug Discovery Software Market Forces
4.4. Porters five force model
4.4.1. Bargaining power of suppliers
4.4.2. Bargaining powers of customers
4.4.3. Threat of new entrants
4.4.4. Rivalry among existing players
4.4.5. Threat of substitutes
5. Computational Medicine And Drug Discovery Software Market -Strategic analysis
5.1. Value chain analysis
5.2. Opportunities analysis
5.3. Product life cycle
5.4. Suppliers and distributors Market Share
6. Computational Medicine And Drug Discovery Software Market – By Tools (Market Size -$Million / $Billion)
6.1. Market Size and Market Share Analysis
6.2. Application Revenue and Trend Research
6.3. Product Segment Analysis
7. Computational Medicine And Drug Discovery Software Market – By Application (Market Size -$Million / $Billion)
7.2. Computational Physiological Medicine
7.3. Drug Discovery and Development
7.4. Medical Imaging
7.5. Disease Modeling
7.6. Predictive Analysis of Drug Targets
7.7. Cellular Simulation
7.8. Simulation Software
7.11. Molecular Biology
7.12. Gene expression analysis
8. Computational Medicine And Drug Discovery Software - By Geography (Market Size -$Million / $Billion)
8.1. Computational Medicine And Drug Discovery Software Market - North America Segment Research
8.2. North America Market Research (Million / $Billion)
8.2.1. Segment type Size and Market Size Analysis
8.2.2. Revenue and Trends
8.2.3. Application Revenue and Trends by type of Application
8.2.4. Company Revenue and Product Analysis
8.2.5. North America Product type and Application Market Size
188.8.131.52. Rest of North America
8.3. Computational Medicine And Drug Discovery Software - South America Segment Research
8.4. South America Market Research (Market Size -$Million / $Billion)
8.4.1. Segment type Size and Market Size Analysis
8.4.2. Revenue and Trends
8.4.3. Application Revenue and Trends by type of Application
8.4.4. Company Revenue and Product Analysis
8.4.5. South America Product type and Application Market Size
184.108.40.206. Costa Rica
220.127.116.11. Rest of South America
8.5. Computational Medicine And Drug Discovery Software - Europe Segment Research
8.6. Europe Market Research (Market Size -$Million / $Billion)
8.6.1. Segment type Size and Market Size Analysis
8.6.2. Revenue and Trends
8.6.3. Application Revenue and Trends by type of Application
8.6.4. Company Revenue and Product Analysis
8.6.5. Europe Segment Product type and Application Market Size
18.104.22.168. Rest of Europe
8.7. Computational Medicine And Drug Discovery Software – APAC Segment Research
8.8. APAC Market Research (Market Size -$Million / $Billion)
8.8.1. Segment type Size and Market Size Analysis
8.8.2. Revenue and Trends
8.8.3. Application Revenue and Trends by type of Application
8.8.4. Company Revenue and Product Analysis
8.8.5. APAC Segment – Product type and Application Market Size
22.214.171.124. South Korea
9. Computational Medicine And Drug Discovery Software Market - Entropy
9.1. New product launches
9.2. M&A's, collaborations, JVs and partnerships
10. Computational Medicine And Drug Discovery Software Market Company Analysis
10.1. Market Share, Company Revenue, Products, M&A, Developments
10.2. Compugen Ltd.
10.5. Dassault Systemes
10.6. Schrödinger LLC
10.7. Genedata AG
11. Computational Medicine And Drug Discovery Software Market -Appendix